In melanoma, CD103+ DCs transport tumor antigens to Draining lymph nodes (dLN) in a CCR7-dependent manner, resulting in increased numbers of tumor-specific CD8+ T cells (53). This evidence concerns the gene CCR7 and neoplasm.